New York 2025-2026 Regular Session

New York Senate Bill S02331

Introduced
1/16/25  
Refer
1/16/25  

Caption

Decriminalizes the possession of buprenorphine from certain crimes.

Summary

Bill S02331 seeks to amend the New York penal law by decriminalizing the possession of buprenorphine, a medication commonly used in the treatment of opioid addiction. The bill specifically modifies the definitions of 'controlled substance' and 'narcotic preparation' to exclude buprenorphine, thereby removing it from the categories of substances that can lead to criminal penalties for possession. This legislative change aims to reduce the stigma associated with buprenorphine and promote its use as a therapeutic option for individuals struggling with substance use disorders.

Impact

The passage of this bill would significantly impact state laws regarding drug possession, particularly in how buprenorphine is treated under the penal code. By decriminalizing this substance, the bill aims to facilitate greater access to treatment for opioid addiction without the fear of legal repercussions. This could lead to a shift in how law enforcement and the judicial system handle cases involving buprenorphine, potentially reducing the number of arrests and prosecutions related to its possession.

Sentiment

The general sentiment surrounding Bill S02331 appears to be supportive among its sponsors and advocates, who argue that decriminalization is a necessary step toward addressing the opioid crisis and improving public health outcomes. However, there may be concerns from some lawmakers or community members about the implications of decriminalizing a substance that is still classified as a controlled substance in other contexts, which could lead to debates on public safety and drug policy.

Contention

Notable points of contention may arise from those who believe that decriminalizing buprenorphine could send the wrong message about drug use and potentially lead to increased misuse. Critics may argue that while the intention is to support treatment, it could inadvertently normalize the possession of controlled substances. Supporters, on the other hand, emphasize the need to prioritize treatment over punishment for individuals struggling with addiction.

Companion Bills

NY A01647

Same As Decriminalizes the possession of buprenorphine from certain crimes.

Previously Filed As

NY A01647

Decriminalizes the possession of buprenorphine from certain crimes.

NY S00699

Decriminalizes the possession of buprenorphine from certain crimes.

NY A1250

Decriminalizes manufacture and certain possession of slingshots.

NY HB07065

An Act Concerning The Decriminalization Of Possession Of Small Amounts Of Psilocybin.

NY SF3473

Residual amounts of controlled substances contained in drug paraphernalia and similar items possession decriminalization

NY SB154

Criminalizes the possession or distribution of kratom. (8/1/25)

NY S08460

Adds possessing a flare gun with intent to use it unlawfully against another to the crime of criminal possession of a weapon in the fourth degree.

NY A4550

Requires health benefits coverage for buprenorphine and buprenorphine/naloxone for pain treatment without step therapy or fail-first protocols.

NY HB2450

Decriminalizes certain prostitution offenses and establishes the offense of commercial sexual exploitation

NY HB06380

An Act Decriminalizing The Possession Of Psilocybin.

Similar Bills

No similar bills found.